Chinese Academy of Sciences is the lead sponsor of 12 current clinical trials in our China register. 10 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Semaglutide. The most-studied condition is Obesity.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Quality Control of Ultrasound Images During Early Pregnancy Via AI
NCT06002412 · ClinicalTrials.gov ↗ · Early Pregnancy
|
Observational | Recruiting | 2023-09 | China |
|
GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma
NCT05047510 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma
|
Not applicable | Recruiting | 2021-09 | China |
|
Research on Identifying Critical Surgical Anatomy in Cholecystectomy Videos Based on Deep Learning
NCT07158372 · ClinicalTrials.gov ↗ · Cholecystectomy, Surgical Video Identification
|
Observational | Recruiting | 2025-08 | China |
|
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
NCT07170345 · ClinicalTrials.gov ↗ · Hepatocellular Carcinoma (HCC), Microvascular Invasion (MVI)
|
Observational | Recruiting | 2025-09 | China |
|
Protein Supplementation Intervention on Body Weight
NCT06989203 · ClinicalTrials.gov ↗ · Obesity, Weight Loss, Protein Supplementation
Drug: Semaglutide |
Not applicable | Recruiting | 2025-06 | China |
|
Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
NCT06002425 · ClinicalTrials.gov ↗ · Gastrointestinal Neoplasm Malignant
|
Not applicable | Recruiting | 2023-08 | China |
|
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
NCT06035250 · ClinicalTrials.gov ↗ · Gastric Cancer, Image, Pathology
|
Observational | Recruiting | 2023-09 | China |
|
Prospective Multicenter Screening for Thoracic Disease Via Radiography
NCT07585214 · ClinicalTrials.gov ↗ · Pulmonary Diseases, Respiratory Disease, Esophageal Diseases
|
Observational | Recruiting | 2026-05 | China |
|
Probiotic Intervention on Body Weight
NCT06989177 · ClinicalTrials.gov ↗ · Obesity, Homeostasis, Weight Loss
Drug: Semaglutide |
Not applicable | Recruiting | 2025-06 | China |
|
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
NCT05722275 · ClinicalTrials.gov ↗ · Gastric Cancer, Peritoneal Metastases
|
Observational | Recruiting | 2023-01 | China |
|
Prospective Collection and Registry Study of Multicenter, Multidisciplinary Surgical Minimally Invasive Videos
NCT07752862 · ClinicalTrials.gov ↗ · Surgical Neoplasms, Abdominal Surgical Diseases, Pelvic Surgical Diseases
|
Observational | Not yet open | 2026-08 | China |
|
Energy Metabolism Profiles Over Weight-loss and Eating Responses
NCT05785221 · ClinicalTrials.gov ↗ · Homeostasis, Metabolism and Nutrition Disorder, Healthy
|
Not applicable | Active, closed | 2023-03 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 12 | 10 |
A trial with sites in more than one country appears in each of those registers.
Sponsors with the most current trials registered for this condition.
Chinese Academy of Sciences is the lead sponsor of 12 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 10 of its 12 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Its current trials name 1 drug or biological as interventions. The most frequent are Semaglutide (2). The number in brackets is how many of its trials name each drug.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.